Sather Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Buy |
+2,762
| New | +$513K | 0.03% | 65 |
|
|
2024
Q2 | – | Sell |
-2,769
| Closed | -$504K | – | 84 |
|
|
2024
Q1 | $504K | Sell |
2,769
-56,790
| -95% | -$10.3M | 0.04% | 57 |
|
|
2023
Q4 | $9.23M | Buy |
59,559
+156
| +0.3% | +$24.2K | 0.68% | 29 |
|
|
2023
Q3 | $8.85M | Buy |
59,403
+613
| +1% | +$91.4K | 0.74% | 29 |
|
|
2023
Q2 | $7.92M | Hold |
58,790
| – | – | 0.63% | 33 |
|
|
2023
Q1 | $9.37M | Hold |
58,790
| – | – | 0.81% | 31 |
|
|
2022
Q4 | $9.5M | Buy |
58,790
+56,777
| +2,821% | +$9.18M | 0.78% | 35 |
|
|
2022
Q3 | $270K | Buy |
2,013
+13
| +0.7% | +$1.74K | 0.03% | 66 |
|
|
2022
Q2 | $306K | Hold |
2,000
| – | – | 0.03% | 66 |
|
|
2022
Q1 | $324K | Buy |
+2,000
| New | +$324K | 0.03% | 70 |
|
|
2020
Q1 | – | Sell |
-3,481
| Closed | -$308K | – | 61 |
|
|
2019
Q4 | $308K | Buy |
3,481
+381
| +12% | +$33.7K | 0.05% | 63 |
|
|
2019
Q3 | $234K | Hold |
3,100
| – | – | 0.04% | 52 |
|
|
2019
Q2 | $225K | Hold |
3,100
| – | – | 0.04% | 52 |
|
|
2019
Q1 | $249K | Hold |
3,100
| – | – | 0.05% | 49 |
|
|
2018
Q4 | $285K | Hold |
3,100
| – | – | 0.06% | 52 |
|
|
2018
Q3 | $293K | Sell |
3,100
-3,000
| -49% | -$284K | 0.06% | 51 |
|
|
2018
Q2 | $565K | Buy |
6,100
+100
| +2% | +$9.26K | 0.13% | 50 |
|
|
2018
Q1 | $568K | Hold |
6,000
| – | – | 0.13% | 49 |
|
|
2017
Q4 | $580K | Hold |
6,000
| – | – | 0.14% | 44 |
|
|
2017
Q3 | $533K | Hold |
6,000
| – | – | 0.15% | 45 |
|
|
2017
Q2 | $435K | Buy |
+6,000
| New | +$435K | 0.13% | 48 |
|